[Retracted] Serum miR ‑338‑5p has potential for use as a tumor marker for retinoblastoma

Oncol Lett. 2024 Mar 19;27(5):215. doi: 10.3892/ol.2024.14347. eCollection 2024 May.ABSTRACT[This retracts the article DOI: 10.3892/ol.2019.10331.].PMID:38572062 | PMC:PMC10988189 | DOI:10.3892/ol.2024.14347

Source: Oncology Letters - April 4, 2024 Category: Cancer & Oncology Authors: Peng Zhou Xuemin Li Source Type: research